Teeple A, Muser E. Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. J of Skin [Internet]. 2017Oct.27 [cited 2025Jan.10];1(3.1):s6. Available from: https://skin.dermsquared.com/skin/article/view/157